Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S.

Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496. Review.

2.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
4.

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.

5.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
6.

Ezetimibe Use and LDL-C Goal Achievement: A Retrospective Database Analysis of Patients with Clinical Atherosclerotic Cardiovascular Disease or Probable Heterozygous Familial Hypercholesterolemia.

Menzin J, Aggarwal J, Boatman B, Yu J, Stern K, Harrison DJ, Patel JG.

J Manag Care Spec Pharm. 2017 Dec;23(12):1270-1276. doi: 10.18553/jmcp.2017.16414. Epub 2017 Sep 25.

9.

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

Gotto AM Jr, Farmer JA.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. Review.

PMID:
17122799
10.

Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.

Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G, Purpura L, Torres D, Campisi D.

Int Angiol. 2010 Dec;29(6):514-24.

PMID:
21173733
11.

[Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results].

Borghi C, Filardi PP.

G Ital Cardiol (Rome). 2015 Jul-Aug;16(7-8 Suppl 1):3S-14S. doi: 10.1714/1972.21370. Italian.

PMID:
26442834
12.

Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.

González CA, Rubio-Guerra AF, Pavía A, Redding FJ, Cervantes JL, Zacarías JL, Yza R, Carranza J, Fernández P, Morales E, Robles FJ, Leyva JL, Rodríguez L.

Clin Drug Investig. 2007;27(5):333-7.

PMID:
17451281
13.

Ezetimibe.

Darkes MJ, Poole RM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(1):67-76; discussion 77-8. Review.

PMID:
14727947
14.

Clinical use of ezetimibe.

Cheng AY, Leiter LA.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Review.

PMID:
14571302
16.

Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.

Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R; LAPLACE-2 Investigators.

JAMA. 2014 May 14;311(18):1870-82. doi: 10.1001/jama.2014.4030.

PMID:
24825642
18.
19.

Ezetimibe: a selective cholesterol absorption inhibitor.

Nutescu EA, Shapiro NL.

Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.

PMID:
14620392
20.

Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients.

Pisciotta L, Fasano T, Bellocchio A, Bocchi L, Sallo R, Fresa R, Colangeli I, Cantafora A, Calandra S, Bertolini S.

Atherosclerosis. 2007 Oct;194(2):e116-22. Epub 2006 Nov 30.

PMID:
17140581

Supplemental Content

Support Center